HomeEverythingEducationTV
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

Dimension Capital raises $800M fund for science and compute intersection

Created at 22 Jul · 1:36 AM1 source↑ Market-relevant
IN SHORT

Dimension Capital announced an $800 million fund, its third and largest to date, focusing on deep-tech companies at the intersection of science and compute. This marks a significant increase from its previous $500 million fund raised just 18 months ago.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$800 millionDimension Capital's new fund size
$500 millionDimension Capital's previous fund size
18 monthsTime between fund announcements
60%Increase in fund size
$30 millionSeed investment in Chai Discovery
$400 millionChai Discovery's recent funding round
$3.8 billionChai Discovery's valuation
$3.1 billionNew Limit's Series C valuation
$400 millionAcquisition price of Coefficient Bio

Who's Involved

Dimension Capital
Venture capital firm that raised an $800 million fund
Zavian Dar
Co-founder of Dimension Capital, formerly of Lux Capital
Adam Goulburn
Co-founder of Dimension Capital, formerly of Lux Capital
Nan Li
Co-founder of Dimension Capital, formerly of Obvious Ventures
Chai Discovery
AI drug development startup backed by Dimension Capital
New Limit
Anti-aging startup backed by Dimension Capital
Brian Armstrong
Co-founder of New Limit and CEO of Coinbase
Anthropic
AI giant that acquired Coefficient Bio
Coefficient Bio
Drug discovery platform acquired by Anthropic
Dimension Capital raises $800M fund for science and compute intersection

↳ Why This Matters

Dimension Capital's successful fundraising and focus on deep tech at the intersection of science and compute highlight a booming sector for venture capital investment, attracting significant capital for innovative startups in areas like AI-driven drug discovery and biotechnology.

Key facts

  • Dimension Capital has raised an $800 million third fund.
  • The new fund is 60% larger than its $500 million second fund.
  • The firm invests in companies at the intersection of science and compute.
  • Notable investments include Chai Discovery, New Limit, and Anthropic.
  • Dimension Capital received shares in Anthropic after it acquired portfolio company Coefficient Bio.

Dimension Capital, a venture capital firm founded in late 2022, has announced its third and largest fund to date, totaling $800 million. This new fund represents a 60% increase compared to its previous $500 million vehicle, which was raised just 18 months prior.

The firm, established by Zavian Dar, Adam Goulburn (formerly of Lux Capital), and Nan Li (formerly of Obvious Ventures), focuses on deep-tech companies operating at the intersection of science and compute, particularly in areas like biotech and software.

Dimension Capital has made several notable investments, including co-leading a $30 million seed round for Chai Discovery, a startup developing open-source AI foundation models for drug development. Chai Discovery recently announced a $400 million funding round at a $3.8 billion valuation.

The firm also backed the anti-aging startup New Limit in its Series A round in January 2025. New Limit, co-founded by Coinbase CEO Brian Armstrong, has since completed a Series C round at a $3.1 billion valuation.

Additionally, Dimension Capital received shares in AI company Anthropic after Anthropic acquired its portfolio company, Coefficient Bio, a drug discovery platform, for a reported $400 million this spring.

Frequently asked questions

Dimension Capital focuses on deep-tech companies that operate at the intersection of science and compute, particularly in areas like biotech and software.

Dimension Capital's new fund is $800 million, making it their largest fund to date.

Notable investments include Chai Discovery, New Limit, and Anthropic (through the acquisition of Coefficient Bio).

Dimension Capital was founded by Zavian Dar, Adam Goulburn, and Nan Li.

What Happens Next

01Dimension Capital will continue to invest in deep-tech companies.
02Chai Discovery will utilize its new funding for AI foundation models in drug development.
03New Limit will advance its anti-aging research and development.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • S&P 500 futures rose as chip stocks led tech rally.
    21 Jul · 8:45 PM
  • S&P 500 futures rose as chip stocks led tech rally.
    21 Jul · 8:45 PM
  • Firm Clearing Trade/Group/Allocation ID Transition Project - Phase 3 Updated Timeline — Effective November 16, 2026
    20 Jul · 9:00 PM

How It Developed

Dimension Capital announced an $800 million fund.
The new fund is 60% larger than its previous $500 million fund.
Dimension Capital's thesis focuses on deep-tech companies at the intersection of science and compute.
The firm co-led a $30 million seed investment in AI drug development startup Chai Discovery.
Dimension Capital backed anti-aging startup New Limit at its Series A round.
New Limit completed a Series C round at a $3.1 billion valuation.
Anthropic acquired Dimension's portfolio company Coefficient Bio for a reported $400 million.
Dimension received shares in Anthropic after the acquisition.

Sources

T1
Dimension Capital’s $800M third fund shows the intersection of science and compute is boomingTechCrunch

Related Stories

Augustus raises $180 million for AI-native clearing bank
21 Jul · 2:31 PM
Amundi CEO eyes Asia growth after SBI Funds Management IPO
21 Jul · 6:31 AM
New York Life Asset Management Expands Japan Private Market Operations
21 Jul · 7:06 AM
Goldman Sachs launches private markets platform for wealthy clients
21 Jul · 8:22 PM
Tesla robotaxi expansion tests investor patience amid AI spending surge
21 Jul · 10:04 AM